Salt repletion and diuretic response: The role of serum chloride. A post‐hoc analysis of the SALT‐HF trial on furosemide and hypertonic saline solution administration in ambulatory patients with worsening heart failure

IF 16.9 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
Julio Núñez, Gema Miñana, Rafael de la Espriella, Isabel Zegrí‐Reiriz, Josep Comín‐Colet, Jorge Rubio Gracia, Jose Luis Morales‐Rull, Pau Llàcer, Pablo Diez‐Villanueva, Javier de Juan Bagudá, Carolina Ortiz Cortés, Josebe Goirigolzarri‐Artaza, Jose Manuel García‐Pinilla, Elvira Barrios, Susana del Prado Díaz, Santiago Jiménez‐Marrero, Maria Alejandra Restrepo‐Córdoba, Jeffrey Testani, Marta Cobo Marcos
{"title":"Salt repletion and diuretic response: The role of serum chloride. A post‐hoc analysis of the SALT‐HF trial on furosemide and hypertonic saline solution administration in ambulatory patients with worsening heart failure","authors":"Julio Núñez, Gema Miñana, Rafael de la Espriella, Isabel Zegrí‐Reiriz, Josep Comín‐Colet, Jorge Rubio Gracia, Jose Luis Morales‐Rull, Pau Llàcer, Pablo Diez‐Villanueva, Javier de Juan Bagudá, Carolina Ortiz Cortés, Josebe Goirigolzarri‐Artaza, Jose Manuel García‐Pinilla, Elvira Barrios, Susana del Prado Díaz, Santiago Jiménez‐Marrero, Maria Alejandra Restrepo‐Córdoba, Jeffrey Testani, Marta Cobo Marcos","doi":"10.1002/ejhf.3597","DOIUrl":null,"url":null,"abstract":"AimsThe efficacy of combining hypertonic saline solution (HSS) with loop diuretics in worsening heart failure (WHF) remains uncertain. Hypochloraemia has been associated with reduced diuretic efficacy. Some authors propose that chloride repletion may enhance natriuretic and diuretic responses. This post‐hoc analysis of the SALT‐HF trial evaluated the effect of single‐dose administration of HSS plus intravenous (IV) furosemide versus IV furosemide, stratified by baseline serum chloride.Methods and resultsThe analysis included 148 ambulatory patients with WHF from the double‐blind, randomized SALT‐HF trial. Participants received either an IV single dose of HSS plus furosemide or IV furosemide. The endpoints were 3‐h urinary sodium excretion and diuresis, 7‐day congestion score, and 30‐day adverse events according to chloride levels. Multivariable linear and logistic regression models assessed the relationship between the intervention and the endpoints. The mean baseline serum chloride level was 100 ± 4 mmol/L. Sixteen patients (10.8%) were identified as hypochloraemic (serum chloride &lt;96 mmol/L), balanced between treatment groups. Patients with hypochloraemia showed a lower natriuretic response (<jats:italic>p</jats:italic> &lt; 0.05). Interaction analysis revealed a between‐treatment differential natriuretic effect based on the chloride levels (<jats:italic>p</jats:italic><jats:sub>interaction</jats:sub> = 0.008). HSS plus furosemide increased natriuresis compared to furosemide at lower chloride levels. No differential between‐treatment effect was found for 3‐h diuresis. Similar heterogeneous results were found for the 7‐day clinical congestion score and 30‐day heart failure events, with a benefit with HSS in patients with lower chloride levels.ConclusionIn ambulatory patients with WHF and hypochloraemia, adding HSS to furosemide may improve short‐term natriuretic response and outcomes. These findings suggest that chloride supplementation may help overcome diuretic resistance in these patients.","PeriodicalId":164,"journal":{"name":"European Journal of Heart Failure","volume":"78 1","pages":""},"PeriodicalIF":16.9000,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ejhf.3597","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

AimsThe efficacy of combining hypertonic saline solution (HSS) with loop diuretics in worsening heart failure (WHF) remains uncertain. Hypochloraemia has been associated with reduced diuretic efficacy. Some authors propose that chloride repletion may enhance natriuretic and diuretic responses. This post‐hoc analysis of the SALT‐HF trial evaluated the effect of single‐dose administration of HSS plus intravenous (IV) furosemide versus IV furosemide, stratified by baseline serum chloride.Methods and resultsThe analysis included 148 ambulatory patients with WHF from the double‐blind, randomized SALT‐HF trial. Participants received either an IV single dose of HSS plus furosemide or IV furosemide. The endpoints were 3‐h urinary sodium excretion and diuresis, 7‐day congestion score, and 30‐day adverse events according to chloride levels. Multivariable linear and logistic regression models assessed the relationship between the intervention and the endpoints. The mean baseline serum chloride level was 100 ± 4 mmol/L. Sixteen patients (10.8%) were identified as hypochloraemic (serum chloride <96 mmol/L), balanced between treatment groups. Patients with hypochloraemia showed a lower natriuretic response (p < 0.05). Interaction analysis revealed a between‐treatment differential natriuretic effect based on the chloride levels (pinteraction = 0.008). HSS plus furosemide increased natriuresis compared to furosemide at lower chloride levels. No differential between‐treatment effect was found for 3‐h diuresis. Similar heterogeneous results were found for the 7‐day clinical congestion score and 30‐day heart failure events, with a benefit with HSS in patients with lower chloride levels.ConclusionIn ambulatory patients with WHF and hypochloraemia, adding HSS to furosemide may improve short‐term natriuretic response and outcomes. These findings suggest that chloride supplementation may help overcome diuretic resistance in these patients.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
European Journal of Heart Failure
European Journal of Heart Failure 医学-心血管系统
CiteScore
27.30
自引率
11.50%
发文量
365
审稿时长
1 months
期刊介绍: European Journal of Heart Failure is an international journal dedicated to advancing knowledge in the field of heart failure management. The journal publishes reviews and editorials aimed at improving understanding, prevention, investigation, and treatment of heart failure. It covers various disciplines such as molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, clinical sciences, social sciences, and population sciences. The journal welcomes submissions of manuscripts on basic, clinical, and population sciences, as well as original contributions on nursing, care of the elderly, primary care, health economics, and other related specialist fields. It is published monthly and has a readership that includes cardiologists, emergency room physicians, intensivists, internists, general physicians, cardiac nurses, diabetologists, epidemiologists, basic scientists focusing on cardiovascular research, and those working in rehabilitation. The journal is abstracted and indexed in various databases such as Academic Search, Embase, MEDLINE/PubMed, and Science Citation Index.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信